Alexandria Real Estate Equities
ARE
#2286
Rank
A$12.06 B
Marketcap
A$69.81
Share price
2.61%
Change (1 day)
-55.42%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2025 (TTM): -A$19.73 Million

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are A$2.97 Billion. In 2024 the company made an earning of A$1.04 Billion, an increase over its 2023 earnings that were of A$0.53 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$19.73 Million-101.89%
2024 A$1.04 B96.11%
2023 A$0.53 B-53.56%
2022 A$1.14 B-3.96%
2021 A$1.19 B-20.26%
2020 A$1.50 B72.88%
2019 A$0.86 B3.11%
2018 A$0.84 B73.54%
2017 A$0.48 B464.88%
2016 A$85.85 M-77.32%
2015 A$0.37 B36.31%
2014 A$0.27 B-10.81%
2013 A$0.31 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$17.80 B-57,124.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$14.85 B-47,665.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$33.80 B-108,373.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$1.49 B-4,887.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$12.06 B-38,749.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.38 B-39,765.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$0.19 B-727.01%๐Ÿ‡บ๐Ÿ‡ธ USA